SCHEMBL17782886

SCHEMBL17782886

Cc1cc2nc(-c3ccc(CN4CCN(C)CC4)cc3)[nH]c2cc1Nc1nccc(-c2cccnc2)n1

nearest known ligand 0.95

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIT P10721 20/20 0.95
ABL1 P00519 2/20 0.62
BCR P11274 2/20 0.62
PDGFRA P16234 2/20 0.62
PLK4 O00444 1/20 0.62
DDX3X O00571 1/20 0.62
GAK O14976 1/20 0.62
SLC22A2 O15244 1/20 0.62
MAPK13 O15264 1/20 0.62
CA12 O43570 1/20 0.62
SLC22A3 O75751 1/20 0.62
ABCB11 O95342 1/20 0.62
EGFR P00533 1/20 0.62
CA1 P00915 1/20 0.62
CA2 P00918 1/20 0.62
LMNA P02545 1/20 0.62
ALB P02768 1/20 0.62
RAF1 P04049 1/20 0.62
ERBB2 P04626 1/20 0.62
LCK P06239 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16365772 0.93 KIT (0.95) KITABL1BCRPDGFRAPLK4
SCHEMBL16365777 0.92 KIT (0.82) KITABL1BCRABL2
SCHEMBL16365770 0.89 KIT (0.96) KITABL1BCRPDGFRAPLK4
SCHEMBL16321597 0.87 KIT (0.96) KITABL1BCRPDGFRAPLK4
SCHEMBL17782819 0.85 KIT (0.83) KITABL1BCRPDGFRAEGFR
SCHEMBL16365789 0.85 KIT (0.94) KITABL1BCR
SCHEMBL16365786 0.84 KIT (0.94) KITABL1BCR
SCHEMBL16321029 0.84 KIT (0.92) KITABL1BCRPDGFRAPDGFRB
SCHEMBL17782781 0.84 KIT (0.95) KIT
SCHEMBL16365874 0.82 KIT (0.86) KIT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10202370-B2 Benzimidazole derivatives as selective proteine kinase inhibitors AB SCIENCE (FR) 2019-02-12 US claimed
US-20160152608-A1 BENZIMIDAZOLE DERIVATIVES AS SELECTIVE PROTEINE KINASE INHIBITORS AB SCIENCE (FR) 2016-06-02 US claimed
EP-3010906-B1 BENZIMIDAZOLE DERIVATIVES AS SELECTIVE PROTEIN KINASE INHIBITORS AB SCIENCE (FR) 2019-06-12 EP disclosed
EP-3010906-B1 BENZIMIDAZOLE DERIVATIVES AS SELECTIVE PROTEIN KINASE INHIBITORS AB SCIENCE (FR) 2019-06-12 EP disclosed
US-10202370-B2 Benzimidazole derivatives as selective proteine kinase inhibitors AB SCIENCE (FR) 2019-02-12 US disclosed
US-10202370-B2 Benzimidazole derivatives as selective proteine kinase inhibitors AB SCIENCE (FR) 2019-02-12 US disclosed
US-20160152608-A1 BENZIMIDAZOLE DERIVATIVES AS SELECTIVE PROTEINE KINASE INHIBITORS AB SCIENCE (FR) 2016-06-02 US disclosed
US-20160152608-A1 BENZIMIDAZOLE DERIVATIVES AS SELECTIVE PROTEINE KINASE INHIBITORS AB SCIENCE (FR) 2016-06-02 US disclosed
US-20160152608-A1 BENZIMIDAZOLE DERIVATIVES AS SELECTIVE PROTEINE KINASE INHIBITORS AB SCIENCE (FR) 2016-06-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10202370-B2 Benzimidazole derivatives as selective proteine kinase inhibitors KIT, CHUK, CSNK1E KIT 1/4885ABL1 121/4885BCR 380/4885
US-20160152608-A1 BENZIMIDAZOLE DERIVATIVES AS SELECTIVE PROTEINE KINASE INHIBITORS KIT, CHUK, CSNK1E KIT 1/4885ABL1 121/4885BCR 380/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.